Skip to main content

Market Overview

Law Offices of Howard G. Smith Announces Investigation of ArthroCare Corporation

Share:
BENSALEM, Pa.--(BUSINESS WIRE)--

Law Offices of Howard G. Smith announces that it is investigating potential claims against the Board of Directors of ArthroCare Corporation (“ArthroCare” or the “Company”) (NASDAQ: ARTC) related to the proposed acquisition of the Company by Smith & Nephew. The transaction is valued at approximately $1.7 billion, or $48.25 per share.

This investigation concerns whether the Board of Directors of ArthroCare breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the proposed transaction, and whether the Company has disclosed all material information to shareholders about the transaction. The Company has seen substantial recent growth. Its share price has skyrocketed from $31.67 on August 30, 2013 to $47.94 on January 23, 2013.

If you are a shareholder of ArthroCare, if you have information or would like to learn more about our investigation, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at 215-638-4847, Toll Free at 888-638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847 or Toll Free: 888-638-4847
howardsmith@howardsmithlaw.com
http://www.howardsmithlaw.com

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com